Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-23-024504
Filing Date
2023-05-15
Accepted
2023-05-15 08:20:46
Documents
76
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q brhc20052759_10q.htm   iXBRL 10-Q 1125539
2 EXHIBIT 10.1 brhc20052759_ex10-1.htm EX-10.1 15368
3 EXHIBIT 10.2 brhc20052759_ex10-2.htm EX-10.2 43941
4 EXHIBIT 31.1 brhc20052759_ex31-1.htm EX-31.1 9600
5 EXHIBIT 31.2 brhc20052759_ex31-2.htm EX-31.2 9182
6 EXHIBIT 32.1 brhc20052759_ex32-1.htm EX-32.1 5766
12 image00001.jpg GRAPHIC 7829
  Complete submission text file 0001140361-23-024504.txt   6250663

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ocup-20230331.xsd EX-101.SCH 58955
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ocup-20230331_cal.xml EX-101.CAL 36118
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ocup-20230331_def.xml EX-101.DEF 269994
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocup-20230331_lab.xml EX-101.LAB 653346
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocup-20230331_pre.xml EX-101.PRE 410056
70 EXTRACTED XBRL INSTANCE DOCUMENT brhc20052759_10q_htm.xml XML 861709
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34079 | Film No.: 23918585
SIC: 2834 Pharmaceutical Preparations